Medically reviewed

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Temazepam

Quick Facts

Property	Description
Active ingredient	Temazepam
Form	Capsule or Tablet (Oral administration)
Pharmacological class	Benzodiazepine; CNS Depressant
Common use	Short-term management of insomnia
Origin	Synthetic (Oxazepam metabolite)

What Type of Drug is Temazepam? (Classification and Origin)

Temazepam is a synthetic medicinal entity and a prescription-only medication that belongs to the benzodiazepine pharmacological class. This classification is clinically recognized by major health authorities, defining its function as a Central Nervous System (CNS) depressant. The drug's intermediate duration of action is a differentiating factor, as it helps manage sleep without the prolonged residual effects sometimes associated with longer-acting compounds. Chemically, Temazepam is identified as 3-hydroxydiazepam, an active oxazepam metabolite. This fundamental classification distinguishes it from non-benzodiazepine hypnotics and supports its unique profile as a controlled substance intended for short-term intervention.

What is Temazepam’s General Purpose and Form? (Function and Composition)

The primary general purpose of Temazepam is to function as a hypnotic or soporific agent for the short-term treatment of insomnia and related sleep disturbance. Its primary role involves facilitating sleep onset and maintenance. This makes it a standard therapeutic option for temporary periods of acute difficulty sleeping. As a single-ingredient product, its only active component is Temazepam, which is formulated for oral administration, meaning it is taken by mouth, typically as a capsule or tablet. Its therapeutic benefit is derived from its ability to enhance the effects of GABA, thereby quickly promoting the restful, sedated state necessary for sleep.

Regulatory References

What side effects are possible with Temazepam?

Possible side effects and safety information

The safety characteristics of Temazepam are officially documented within regulatory documents, predominantly reflecting its action as a Central Nervous System (CNS) depressant. Adverse reactions are formally categorized by frequency and the physiological systems affected, based on clinical trial and post-marketing data.

Official Adverse Reaction Categories

Adverse effects are commonly classified into Nervous system disorders and Psychiatric disorders in official labeling. Reactions classified as Common include drowsiness, dizziness, fatigue, and headache. Less frequent, or Uncommon/Rare, reactions may involve confusion, ataxia (loss of coordination), and slurred speech.

Serious Adverse Reactions and Safety Patterns

The official safety profile highlights several serious adverse reactions. Anterograde Amnesia, which is memory impairment concerning events that occur after administration, is documented, particularly at higher doses. The risk of developing physical and psychological dependence is a critical, duration-related safety pattern, explicitly noted to increase with both the dose and the duration of use. Subsequent abrupt cessation can result in severe Withdrawal Reactions, including seizures.

Population-Specific Safety Considerations

Regulatory documents specify safety considerations for certain patient groups. Older Adults are noted to have heightened sensitivity, which increases the risk of sedation, confusion, and resultant falls. Furthermore, the medication is subject to safety restrictions, including contraindications or cautions in patients with conditions such as severe respiratory insufficiency or severe hepatic impairment, due to potential respiratory risk or impaired drug clearance.

Overdose and Emergency Response

Temazepam overdose is officially documented as presenting with a progressive spectrum of Central Nervous System (CNS) depression. Initial manifestations include drowsiness, confusion, and slurred speech, escalating to more severe signs such as decreased or absent reflexes, profound stupor, and coma. The regulatory profile recognizes serious, life-threatening outcomes, including hypotension (low blood pressure) and severe respiratory depression.

The risk of death and severe CNS consequences is explicitly increased when Temazepam is co-ingested with other CNS depressants, notably opioids. Immediate medical attention is required for any suspected overdose; emergency services must be contacted, and a Poison Center should be consulted for official management guidance.

Overdose management is stated as being primarily symptomatic and supportive. The specific benzodiazepine antidote, Flumazenil, is available but its use is constrained by regulatory warnings regarding the potential to cause seizures. Elderly patients are noted as being more susceptible to these CNS depressant effects. Continuous patient observation, including monitoring for re-sedation following supportive measures, is a required procedural element of care.

Therapeutic Uses of Temazepam

What Temazepam Treats: Main Uses and Benefits

Temazepam is used for the short-term treatment of insomnia, and its role is to address the specific symptoms that interfere with rest. It is relevant for easing difficulty falling asleep or staying asleep.

Addressing Difficulty Falling Asleep (Sleep Latency)

This medication is applied in clinical settings that involve symptoms related to heightened physiological activity. It is relevant when difficulty initiating sleep becomes a noticeable interference with daily comfort. The therapeutic benefit is primarily to assist with initiating sleep, which helps patients cope more steadily with difficult episodes by easing the initial struggle to achieve rest.

Improving Sleep Maintenance and Continuity

Temazepam is relevant in areas where short-term symptom management is appropriate for fragmented sleep patterns. It is used for managing symptoms that interfere with daily comfort, such as frequent nocturnal awakenings and premature early morning awakenings. It provides support that helps ease the overall symptom burden by supporting a greater continuity of rest, assisting with maintaining a sense of stability.

Support for Transient, Clinically Significant Insomnia

The medication is commonly used across conditions characterized by periods of heightened symptoms of sleep disturbance. It is applied during phases when symptoms become temporarily overwhelming, such as those related to acute stress or travel (transient insomnia). This use is relevant when supportive symptom management is appropriate, as it contributes to easing the overall symptom load and supports the patient during difficult episodes by easing distress.

Quick Fact: Symptom Management for Sleep Disruption The main therapeutic domain for Temazepam is the short-term relief of three primary symptomatic clusters of insomnia: difficulty initiating sleep, frequent nocturnal awakenings, and premature morning awakening.

“The medication's role is to provide supportive symptomatic relief during temporary periods of acute sleep struggle, assisting the patient during periods of acute sleep struggle.”

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Temazepam eligibility is strictly defined by regulatory authorities and is generally restricted to the adult population for short-term use.

Contraindicated Populations

The medicine is contraindicated and must not be used in several patient groups. This absolute exclusion applies to women who are or may become pregnant due to the potential for fetal harm. Contraindications also extend to any patient with a known hypersensitivity to any benzodiazepine, as well as those with acute pulmonary insufficiency, severe respiratory depression, severe hepatic insufficiency, or sleep apnoea syndrome.

Age-Specific and Comorbidity Limitations

Regarding age, safety and efficacy have not been established for children under 18 years of age, and use is not recommended. Older adults may use Temazepam, but regulators advise prescribing the lowest effective dose and exercising special caution due to potential increased sensitivity and risks such as falls.

Use requires caution and monitoring for specific conditions, including chronic pulmonary insufficiency, impaired renal (kidney) or hepatic (liver) function, and a history of alcohol or drug abuse/dependence. For women who are breastfeeding, caution should be exercised as the drug may pass into breast milk, and use is generally not recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Temazepam is primarily defined by the Pharmacodynamic Reinforcement of its central nervous system (CNS) depressant effect.

Documented Interaction Patterns

Classification	Interacting Substance / Class	Official Constraint or Outcome
Severe PD Reinforcement	Opioids (e.g., narcotic analgesics)	Concomitant use may result in profound sedation, respiratory depression, coma, and death (FDA Boxed Warning).
Contraindicated Combination	Drugs that reduce seizure threshold (e.g., Tricyclic Antidepressants)	Formal prohibition due to severe risk [HPRA SmPC].
Additive CNS Depression	Other CNS Depressants	Potentiation of the central depressive effect; includes barbiturates, antihistamines, antipsychotics, and muscle relaxants.
PD Antagonism	Theophylline or Aminophylline	May reduce the sedative effects of Temazepam.

Pharmacokinetic and Substance Notes

Temazepam's primary metabolic pathway is conjugation (Phase II), and it is documented to be largely devoid of significant Cytochrome P450 (CYP) enzyme interactions.

Alcohol (Ethanol): Intake is not recommended as it enhances the sedative effects and increases the risk of side effects such as confusion [HPRA SmPC].
Population Notes: The elderly may experience a prolonged elimination half-life and are more susceptible to the effects of CNS depressants, which enhances the possibility of interaction [HPPA SmPC]. Caution is also advised in patients with renal or hepatic dysfunction due to altered clearance.

Mechanism of Action

How Temazepam Works

Temazepam is a benzodiazepine that acts within the Central Nervous System ( CNS) by functioning as a positive allosteric modulator (PAM) of the GABAA receptor complex. This receptor is the primary mediator of inhibitory neurotransmission in the brain.

Temazepam binds to a specific, non- GABA site located at the interface of the alpha and gamma subunits of the receptor. This binding does not directly activate the receptor but, when GABA is also present, it potentiates the effect of GABA by increasing the frequency of the opening of the receptor's intrinsic chloride ion ( Cl^-) channel.

The resulting increased influx of negatively charged Cl^- ions across the neuronal membrane causes the cell to hyperpolarize. This hyperpolarization elevates the cell's firing threshold, making the neuron significantly less excitable. The net intracellular consequence is a widespread reduction in overall neuronal communication and excitability throughout the CNS, resulting in a generalized depressant physiological effect.

Dosage and Administration Information

How to Use Temazepam

Temazepam is administered solely via the oral route, primarily available in the form of capsules or tablets at strengths such as 7.5 mg, 15 mg, and 30 mg. The use of the medication is structured around a specific, time-constrained protocol.

Official Administration Protocol

The standard adult dosing schedule requires the medicine to be taken as a single dose once daily. The typical adult regimen starts at 15 mg, although a lower dose of 7.5 mg may be prescribed initially, particularly for older or debilitated patients. The dose must be administered immediately before going to bed and only when the patient is certain they can obtain a full night's sleep, typically defined as 7 to 8 hours.

Duration and Cessation

Temazepam is strictly designated for short-term treatment, generally limited to 7 to 10 consecutive days of use. Treatment should not exceed a maximum duration of four weeks, including the period required for dose tapering. Discontinuation of therapy requires a gradual reduction (tapering) of the dose to manage the physiological adjustments associated with ending the course of treatment, as abrupt cessation is discouraged.

Population Group	Labeled Starting Dose/Guidance
Adults (Insomnia)	15 mg (range 7.5 mg to 30 mg)
Older Adults/Debilitated	7.5 mg starting dose

Recent Clinical Evidence

Temazepam: Recent Clinical Evidence

Summary of Clinical Trials

Temazepam, a benzodiazepine, has been evaluated in clinical trials for its use in the short-term management of insomnia. Research regarding the drug's mechanism of action explores its role as a positive allosteric modulator of the GABA-A receptor, which leads to sedative and hypnotic effects.

Studies focused on key sleep metrics, including sleep latency (time taken to fall asleep) and total sleep time. A linear dose-response was observed in total sleep time, with significant drug-placebo differences noted primarily at higher doses in some trials. Findings also indicated that temazepam may be more effective for maintaining sleep than for significantly reducing the time required to fall asleep, depending on the study design and dosage.

Tolerability and Adverse Events Profile

Research examined the tolerability and adverse events of temazepam, particularly in short-term use. Common adverse events reported in the studies include drowsiness, dizziness, and headache. In general, temazepam has an intermediate half-life and no active metabolites, which research suggests may contribute to a lower incidence of residual morning sedation (hangover effect) compared to some longer-acting benzodiazepines.

Finding Area	Key Study Observation
Efficacy	Improvement in total sleep time and reduction in nightly awakenings.
Safety	Common events are dose-related; less morning residual effect than long-acting agents.
Risk	Potential for tolerance and dependence increases with prolonged or higher-dose use.

Studies underscore that the risk of physical dependence and withdrawal symptoms increases with duration of use, which reinforces the recommendation for short-term prescribing. Caution is advised in older adult patients due to an increased risk of confusion, dizziness, and falls.

Frequently Asked Questions (FAQ)

Common questions about Temazepam (FAQ)

Q: What kind of medicine is Temazepam?

According to the official product information, Temazepam belongs to a class of medicines known as benzodiazepines. These types of medicines are used to treat insomnia, or trouble sleeping, by acting as central nervous system depressants. Its use is officially intended only for short-term treatment.

Q: What is the official/approved use for Temazepam?

Official regulatory documents state that Temazepam is approved for the short-term treatment of insomnia. This includes difficulties falling asleep, staying asleep, or waking too early. Its use is generally recommended for conditions where the insomnia is deemed severe, disabling, or causes significant distress.

Q: Does Temazepam help with anxiety?

While Temazepam is chemically part of the benzodiazepine class, which can treat anxiety, the official regulatory approval for this specific product targets the short-term treatment of insomnia. Its use for managing generalized anxiety disorder is not typically the approved indication found on the product label.

Q: How quickly does Temazepam usually start working?

Official information indicates that Temazepam is rapidly absorbed after being taken. Regulatory information indicates the medicine is generally absorbed quickly. Specific details on absorption rates are typically found within the official product information.

Q: How long does Temazepam stay in the body?

Studies and official information indicate that Temazepam has a relatively short duration of action compared to many other benzodiazepines. Official data indicates that Temazepam is characterized by a relatively short half-life, meaning it is eliminated from the body comparatively quickly.

Q: Can Temazepam cause physical or psychological dependence?

According to the official product information, Temazepam, like other benzodiazepines, has the potential to cause both physical and psychological dependence. The potential risk is generally recognized as being higher with prolonged use or increased doses, which is why official recommendations typically limit treatment duration to short periods.

Q: Can I drive a car the morning after taking Temazepam?

Official warnings state that Temazepam can cause drowsiness, dizziness, and impaired motor function, which may continue into the following day. Due to the potential for impairment, the regulatory label advises against driving or operating complex machinery until a person knows how the medicine affects them.

Q: What is 'rebound insomnia' and is it a risk with Temazepam?

Rebound insomnia is a condition where the sleep problems temporarily worsen when a person stops taking a sleep medicine. Regulatory documents indicate that this is a recognized possibility when discontinuing Temazepam, particularly if treatment is stopped suddenly. To minimize the risk of withdrawal symptoms or rebound effects, official guidance typically recommends a gradual discontinuation of the medication.

How should Temazepam be stored and disposed of?

How to Store and Dispose of Temazepam

Storage Conditions

Temazepam must be stored at Controlled Room Temperature, specifically between 68 F to 77 F (20 C to 25 C). The medication must be kept in the container it came in, which should be tightly closed and light-resistant, and stored away from moisture and excess heat. It is strictly required to keep the medicine from freezing.

Security and Child Safety

Due to its classification as a Federal Controlled Substance, temazepam must be stored in a safe, secure location to prevent misuse and theft. The medication must be kept out of the sight and reach of children.

Disposal Requirements

All unused or outdated temazepam must be discarded promptly. Patients must adhere to local requirements for the proper disposal of controlled substances. Official instructions advise against throwing away medicines via wastewater or ordinary household waste and recommend consulting a healthcare professional for guidance on disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.